Navigation Links
Charles Hauser, John Vann named to PMG Research Board of Directors
Date:8/7/2014

Winston-Salem, NC (PRWEB) August 07, 2014

PMG Research, Inc. announced today the election of its Board of Directors. Charles Hauser, CEO of Piedmont Stone Center, and John Vann, a business management consultant at The Summit Companies, will join Jennifer Byrne, Chairman of the Board and CEO of PMG Research, and Joel Lanik, Partner at Frontier Capital, as Directors on PMG Research Board.

PMG Research is a network of sites that provide clinical research services to pharmaceutical companies and CROs, with access to 1.7 million patient lives through its partnerships with large physician practices and integrated health systems. PMG Research is comprised of 10 hub site locations in the Southeastern United States and spans 53 physician practices.

“I am pleased to be a member of the PMG Research Board of Directors,” states Charles Hauser. “I look forward to the opportunity to continue to support PMG’s vision and drive for innovation within the clinical trials industry.” From 1980 to 2006, Mr. Hauser was the President and co-founder of Piedmont Medical Research Associates, now PMG Research. He has served on numerous corporate and community Boards, including the State Health Coordinating Council and the North Carolina Medical Care Commission.

John Vann has extensive experience in the clinical research industry, having co-founded Clinical Trial Management Services (CTMS) followed by several years in corporate development with a leading UK-based CRO. “I look forward to participating on the Board of PMG Research. PMG has a reputation for quality and experience, with a strong focus on patient engagement and strategic development that will help define the new landscape in clinical research,” explains Mr. Vann.

“We are grateful for the participation of Mr. Hauser and Mr. Vann on our Board of Directors. They bring an immense breadth of experience and insight, and their guidance will prove valuable as PMG continues to find innovative ways to partner with healthcare, pharma, and CROs to achieve our mission: bringing clinical research to as many lives as possible,” states Jennifer Byrne.

About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.pmg-research.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076432.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Professor Charles Lieber receives Israels Wolf Prize
2. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
3. BioMed Realty Acquires 320 Charles In Cambridge, MA
4. Elsevier Announces 2013 Library Connect Charleston Conference Award
5. Cleveland Heart Founder Dr. Charles Richardson Appointed to ReliantHeart Board of Directors
6. Charles M. Lieber receives the first Nano Research Award
7. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
8. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
9. Sequenom Named to NASDAQ Global Select Market
10. U of Toronto experiment named top breakthrough of 2011 by Physics World
11. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... and BEIJING , Nov. 30, 2016 ... provider of genomic services and solutions with cutting edge ... it has completed a USD $75 Million [515 Million ... Ltd.,s CMB International Capital Management ( Shenzhen ... Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment ...
(Date:11/30/2016)... 30, 2016   Merck , a leading science ... into a set of agreements with Evotec AG, whereby ... of genetic reagents such as CRISPR and shRNA libraries. ... offers an accelerated pathway to explore and identify new ... identification of new targets, a process that can be ...
(Date:11/30/2016)... Park, NC (PRWEB) , ... November 30, 2016 ... ... company engaged in the development of a new orally administered treatment for Alzheimer’s ... and neuroimaging results of a Phase 2a clinical trial of T3D-959 in mild ...
(Date:11/30/2016)... Toronto, ON (PRWEB) , ... November 30, 2016 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) (announced on November 3, 2016) blocked propagation of toxic, prion-like forms ...
Breaking Biology Technology:
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
(Date:11/17/2016)... 2016 Global Market Watch: Primarily supported ... Population-Based Banks and Academics) market is to witness a value ... shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% ... the analysis period 2014-2020. North America ... by Europe at 9.56% respectively. ...
(Date:11/16/2016)... , Nov. 16, 2016 Sensory Inc ... and security for consumer electronics, and VeriTran ... and retail industry, today announced a global partnership ... way to authenticate users of mobile banking and ... TrulySecure™ software which requires no specialized biometric ...
Breaking Biology News(10 mins):